Recursion Pharmaceuticals, Inc. RXRX Contract Assets
Contract Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNetCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s contract assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s contract assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported contract assets of $5.2M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s contract assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s contract assets decreased by 16.1% year-over-year, from $6.2M to $5.2M.
- What does contract assets mean?
- Revenue recognized under ASC 606 where the right to payment is conditional on something other than the passage of time — work performed but not yet billable.